Literature DB >> 656264

The inhibiton of adrenergically provoked renin release by salbutamol in man.

R Wiggins, R Davies, I Basar, J D Slater.   

Abstract

1 The beta-adrenoceptor agonist salbutamol is shown to have antagonist properties by its effect on adrenergically provoked renin release in normal people. 2 It significantly reduces the rate of renin secretion provoked by either endogenous (85 dregrees head-up tilt) or exogenous (isoprenaline infusion) adrenergic stimulation. 3 Because renin is relatively simple to measure, and because in acute studies its release is relatively uninfluenced by the vagaries of direct and reflex cardiovascular effects, we suggest that, in the characterization of drugs which act on adrenergic beta-receptors, an assessment of their effects on renin release would be useful.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656264      PMCID: PMC1429274          DOI: 10.1111/j.1365-2125.1978.tb01626.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  The effect of isoprenaline on plasma renin activity in man: a dose-response curve.

Authors:  R Davies; J D Slater; M Rudolf; D M Geddes
Journal:  Clin Endocrinol (Oxf)       Date:  1977-05       Impact factor: 3.478

2.  Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I.

Authors:  J Menard; K J Catt
Journal:  Endocrinology       Date:  1972-02       Impact factor: 4.736

3.  [Effect of isoproterenol on renin release].

Authors:  T Inoue
Journal:  Nihon Jinzo Gakkai Shi       Date:  1973-08

4.  Is the adrenergic control of renin release dominant in man?

Authors:  R Davies; J D Slater
Journal:  Lancet       Date:  1976-09-18       Impact factor: 79.321

  4 in total
  1 in total

1.  Hypokalaemia due to salbutamol overdosage.

Authors:  I A O'Brien; J Fitzgerald-Fraser; I G Lewin; R J Corrall
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.